Tramadol Hydrochloride
Product Images NDC 43353-072

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 43353-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 50mg (43353 072)

Bottle Label 50mg (43353 072)
Label for Tramadol Hydrochloride 50 mg tablets, containing 15 tablets per package. The label includes warnings about habit forming potential, storage instructions, and specifies that the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC. The original manufacturer is Amneal Pharmaceuticals of NY, Hauppauge, NY. The label also indicates the product is RX only and includes NDC number 43353-0072.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure of Tramadol Hydrochloride illustrating its molecular configuration with labeled functional groups including methoxy, hydroxyl, and dimethylamine substituents alongside the hydrochloride component.*
FDA Label Image

7bb9a2e6-figure-02 (Tramadol HCl Tablets Usp 2)

7bb9a2e6-figure-02 (Tramadol HCl Tablets Usp 2)
A pharmacokinetic curve showing concentration (ng/mL) versus time (hours) for Tramadol Hydrochloride and its metabolite M1. The graph compares multiple dose and single dose profiles indicated by different line styles for both Tramadol and M1 over a 48-hour period.*
FDA Label Image

7bb9a2e6-figure-03 (Tramadol HCl Tablets Usp 3)

7bb9a2e6-figure-03 (Tramadol HCl Tablets Usp 3)
A line graph from Protocol CAPSS-047 illustrating the time to discontinuation due to nausea/vomiting for patients on 200 mg/day over a 25-day double-blind period. The y-axis represents the percent discontinuing, increasing from 0% to 50%, while the x-axis indicates days in the study. The graph shows a stepwise increase in discontinuation over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.